Altamira Therapeutics Ltd
NASDAQ:CYTO

Watchlist Manager
Altamira Therapeutics Ltd Logo
Altamira Therapeutics Ltd
NASDAQ:CYTO
Watchlist
Price: 1.56 USD
Updated: May 20, 2024
CYTO
/
Income Statement
/
Operating Expenses

Altamira Therapeutics Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Altamira Therapeutics Ltd
Operating Expenses Peer Comparison

Comparables:
NOVN
NLSP
ROG
S
SDZ

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Altamira Therapeutics Ltd
NASDAQ:CYTO
Operating Expenses
-CHf5.9m
CAGR 3-Years
-4%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Novartis AG
SIX:NOVN
Operating Expenses
-$27.2B
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
-1%
NLS Pharmaceutics AG
NASDAQ:NLSP
Operating Expenses
-$15.5m
CAGR 3-Years
-54%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Roche Holding AG
SIX:ROG
Operating Expenses
-CHf24.6B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-4%
S
Sandoz Group AG
SIX:SDZ
Operating Expenses
-$2.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Altamira Therapeutics Ltd's Operating Expenses?
Operating Expenses
-5.9m CHF

Based on the financial report for Dec 31, 2023, Altamira Therapeutics Ltd's Operating Expenses amounts to -5.9m CHF.

What is Altamira Therapeutics Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
12%

Over the last year, the Operating Expenses growth was 53%. The average annual Operating Expenses growth rates for Altamira Therapeutics Ltd have been -4% over the past three years , 12% over the past five years .

ALPHA SPREAD
Join more than 138,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.